SpyGlass Pharma (SGP) Financial Statements

14 Followers

SpyGlass Pharma Financial Overview

SpyGlass Pharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is -9.34; SpyGlass Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25
Income Statement
Total Revenue	$ 0.00
Gross Profit	$ -612.00K
Operating Income	$ -41.45M
EBITDA	$ -40.84M
Net Income	$ -39.87M
Balance Sheet
Cash & Short-Term Investments	$ 107.44M
Total Assets	$ 115.87M
Total Debt	$ 1.58M
Net Debt	$ -94.78M
Total Liabilities	$ 214.70M
Stockholders' Equity	$ -98.84M
Cash Flow
Free Cash Flow	$ -33.49M
Operating Cash Flow	$ -32.70M
Investing Cash Flow	$ -11.79M
Financing Cash Flow	$ 124.58M

Currency in USD

SpyGlass Pharma Earnings and Revenue History

Income Statement >

SpyGlass Pharma Debt to Assets

Balance Sheet >

SpyGlass Pharma Cash Flow

Cash Flow >

SpyGlass Pharma Forecast EPS vs Actual EPS

Earnings >